The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 45 of the 50 references it cites were found in a registry or an index.
Abstract
Observational studies have indicated an inverse association between vitamin D levels and the risk of diabetes, yet evidence from population interventions remains inconsistent. PubMed, EMBASE, Cochrane Library and ClinicalTrials.gov were searched up to September 2017. Data from studies regarding serum 25(OH)D, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were pooled. Twenty studies (n = 2703) were included in the meta-analysis. Vitamin D supplementation resulted in a significant improvement in serum 25(OH)D levels (weighted mean difference (WMD) = 33.98; 95%CI: 24.60–43.37) and HOMA-IR (standardized mean difference (SMD) = −0.57; 95%CI: −1.09~−0.04), but not in other outcomes. However, preferred changes were observed in subgroups as follows: short-term (WMDFBG = −8.44; 95%CI: −12.72~−4.15), high dose (WMDFBG = −8.70; 95%CI: −12.96~−4.44), non-obese (SMDFasting insulin = −1.80; 95%CI: −2.66~−0.95), Middle Easterners (WMDFBG = −10.43; 95%CI: −14.80~−6.06), baseline vitamin D deficient individuals (WMDFBG = −5.77; 95%CI: −10.48~−1.05) and well-controlled HbA1c individuals (WMDFBG = −4.09; 95%CI: −15.44~7.27). Vitamin D supplementation was shown to increase serum 25(OH)D and reduce insulin resistance effectively. This effect was especially prominent when vitamin D was given in large doses and for a short period of time, and to patients who were non-obese, Middle Eastern, vitamin D deficient, or with optimal glycemic control at baseline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“The strength of the evidence was categorized as high, moderate, low or very low [19].”
BackgroundVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationHolick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,001
Vitamin D and type 2 diabetes: a systematic review
Mitri, J., Muraru, M. D., & Pittas, A. G. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.118 · Cited by 570
Sugden, J. A., Davies, J. I., Witham, M. D., Morris, A. D., & Struthers, A. D. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02360.x · Cited by 554 · cited 2×
“Vitamin D3 was used in 17 studies and vitamin D2 in one study [35], while the other two failed to report the type in detail [31,38].”
BackgroundMethodBlood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes
Song, Y., Wang, L., Pittas, A. G., Del Gobbo, L. C., Zhang, C., Manson, J. E., & Hu, F. B. (2013) · Diabetes Care · doi:10.2337/dc12-0962 · Cited by 510
Worldwide status of vitamin D nutrition
Lips, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.021 · Cited by 459 · cited 1×
“In addition, studies found that populations with darker skin color and cultural preferences toward less exposure to the sun, which matched the profile of Middle Easterners, were at a higher risk of vitamin D deficiency, and that, in turn, was associated with better effects from supplementation [42,43].”
BackgroundWitham, M. D., Dove, F. J., Dryburgh, M., Sugden, J. A., Morris, A. D., & Struthers, A. D. (2010) · Diabetologia · doi:10.1007/s00125-010-1838-1 · Cited by 269
Jorde, R., & Figenschau, Y. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0020-3 · Cited by 244 · cited 2×
“[26] and trials carrying a high risk of bias [24,26,36].”
BackgroundGysemans, C. A., Cardozo, A. K., Callewaert, H., Giulietti, A., Hulshagen, L., Bouillon, R., Eizirik, D. L., & Mathieu, C. (2005) · Endocrinology · doi:10.1210/en.2004-1322 · Cited by 212
Mirhosseini, N. Z., Vatanparast, H., Mazidi, M., & Kimball, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01024 · Cited by 179 · cited 3×
“Some observational studies indicated that supraphysiological dosing of vitamin D could be harmful; however, the most common dosing of supplementation, 2000 IU/day, was much lower than that, as well as than the debated dosing required for efficacy, 4000 to 5000 IU/day [13,40].”
BackgroundResultVitamin D Levels and Mortality in Type 2 Diabetes
Joergensen, C., Gall, M.-A., Schmedes, A., Tarnow, L., Parving, H.-H., & Rossing, P. (2010) · Diabetes Care · doi:10.2337/dc10-0582 · Cited by 167
Kampmann, U., Mosekilde, L., Juhl, C. B., Møller, N., Christensen, B., Rejnmark, L., Wamberg, L., & Ørskov, L. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.008 · Cited by 162 · cited 3×
“were excluded and an alternative summary statistic was used [25,27].”
BackgroundMethodPark, S., Kim, D. S., & Kang, S. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.09.013 · Cited by 148
Wu, C., Qiu, S., Zhu, X., & Li, L. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.006 · Cited by 146
Zhou, Q. G., Hou, F. F., Guo, Z. J., Liang, M., Wang, G. B., & Zhang, X. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.873 · Cited by 145
Krul-Poel, Y. H. M., ter Wee, M. M., Lips, P. T. A. M., & Şimşek, S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0391 · Cited by 144
Krul-Poel, Y. H. M., Westra, S., ten Boekel, E., ter Wee, M. M., van Schoor, N. M., van Wijland, H., Stam, F., Lips, P. T. A. M., & Şimşek, S. (2015) · Diabetes Care · doi:10.2337/dc15-0323 · Cited by 133 · cited 3×
“were excluded and an alternative summary statistic was used [25,27].”
BackgroundMethodLee, C. J., Iyer, G. S., Liu, Y., Kalyani, R. R., Bamba, N., Ligon, C., Varma, S., & Mathioudakis, N. N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.019 · Cited by 125 · cited 1×
“that longer durations of supplementation were associated with larger reductions in glycemic control, which was possibly due to the 2–3 month lifespan of HbA1c [11,13], our results were in line with Krul-Poel et al.”
ResultSelf-citationGrimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., & Jorde, R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03092.x · Cited by 122
Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., & Esmaillzadeh, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3313-x · Cited by 98 · cited 1×
“[26] and trials carrying a high risk of bias [24,26,36].”
BackgroundSadiya, A., Ahmed, S. M., Carlsson, M., Tesfa, Y., George, M., Ali, H., Siddieg, H. H., & Abusnana, S. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.251 · Cited by 88
Ryu, O.-H., Chung, W., Lee, S., Hong, K.-S., Choi, M.-G., & Yoo, H. J. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.620 · Cited by 86 · cited 2×
“Only two trials applied vitamin D and calcium co-supplementation (same doses of calcium also given to control groups) [32,33].”
BackgroundMethodRyu, O., Lee, S., Yu, J., Choi, M. G., Yoo, H. J., & Mantero, F. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0356 · Cited by 84 · cited 2×
“Only two trials applied vitamin D and calcium co-supplementation (same doses of calcium also given to control groups) [32,33].”
BackgroundMethodHaroon, N. N., Anton, A., John, J. S., & Mittal, M. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0130-9 · Cited by 80 · cited 4×
“However, vitamin D supplementation produced significant decreases in the following subgroups: Middle Easterners, dose > 2000 IU/day, study duration ≤ 3 months and baseline vitamin D deficient (Table 2).”
BackgroundInfluentialNasri, H., Behradmanesh, S., Maghsoudi, A. R., Ahmadi, A., Nasri, P., & Rafieian‐Kopaei, M. (2014) · PubMed Central · doi:10.12861/jrip.2014.10 · Cited by 70
The TIDE Trial Investigators (2011) · Diabetologia · doi:10.1007/s00125-011-2357-4 · Cited by 62 · cited 2×
“Punthakee 2012 [30] 33 countries 607/614 40.”
BackgroundRad, E. Y., Djalali, M., Koohdani, F., Saboor-Yaraghi, A. A., Eshraghian, M. R., Javanbakht, M. H., Saboori, S., Zarei, M., & Hosseinzadeh‐Attar, M. J. (2014) · PubMed Central · Cited by 62
Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients.
Eftekhari, M. H., Akbarzadeh, M., Dabbaghmanesh, M. H., & Hasanzadeh, J. (2011) · PubMed · Cited by 61
Ghavamzadeh, S., Mobasseri, M., & Mahdavi, R. (2014) · PubMed Central · Cited by 53
SORIC, M. M., RENNER, E. T., & SMITH, S. R. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00164.x · Cited by 52
Kim, H.-J., Kang, C.-K., Park, H., & Lee, M.-G. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.3.249 · Cited by 48 · cited 3×
“Only four (n = 364) out of 20 randomized controlled trials measured fasting insulin [21,25,26,38].”
BackgroundWang, G., Li, Y., Li, L., Yu, F., Cui, L., Ba, Y., Li, W., & Wang, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005617 · Cited by 40 · cited 1×
“demonstrated that vitamin D-binding protein polymorphism was associated with increased susceptibility to T2D in Asians, but not in Caucasians; this might explain the heterogeneous responses between Asians and the other groups [41].”
BackgroundAnyanwu, A., Fasanmade, O. A., Odeniyi, I. A., Iwuala, S. O., Coker, H. A. B., & Ohwovoriole, A. E. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.176345 · Cited by 38 · cited 1×
“Among those, eight enrolled Middle Easterners [21–23,29,31,34,36,38], four enrolled individuals from other Asian countries [26,32,33,39], seven enrolled other ethnicities [20,24,25,27,28,35,37] and the one was conducted in 33 countries [30], with participants mainly from 48 to 67 years old.”
BackgroundMaggi, S., Siviero, P., Brocco, E., Albertin, M., Romanato, G., & Crepaldi, G. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0540-4 · Cited by 35 · cited 1×
“Among those, eight enrolled Middle Easterners [21–23,29,31,34,36,38], four enrolled individuals from other Asian countries [26,32,33,39], seven enrolled other ethnicities [20,24,25,27,28,35,37] and the one was conducted in 33 countries [30], with participants mainly from 48 to 67 years old.”
BackgroundBaziar, N., Jafarian, K., Shadman, Z., Qorbani, M., Khoshniat Nikoo, M., & Abd Mishani, M. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.21458 · Cited by 35 · cited 1×
“Only four (n = 364) out of 20 randomized controlled trials measured fasting insulin [21,25,26,38].”
BackgroundZhou, W. P., & Ye, S. (2015) · Journal of Diabetes Research · doi:10.1155/2015/815949 · Cited by 22 · cited 1×
“Among those, eight enrolled Middle Easterners [21–23,29,31,34,36,38], four enrolled individuals from other Asian countries [26,32,33,39], seven enrolled other ethnicities [20,24,25,27,28,35,37] and the one was conducted in 33 countries [30], with participants mainly from 48 to 67 years old.”
BackgroundRajan, S., Weishaar, T., & Keller, B. (2016) · Public Health Nutrition · doi:10.1017/s1368980016000173 · Cited by 22 · cited 1×
“In addition, studies found that populations with darker skin color and cultural preferences toward less exposure to the sun, which matched the profile of Middle Easterners, were at a higher risk of vitamin D deficiency, and that, in turn, was associated with better effects from supplementation [42,43].”
BackgroundRashidi, H., Ghaderian, S. B., Shirinpour, Z., Yazdanpanah, L., Kaykhaei, M. A., Aleali, A. M., Latifi, S. M., & Bazdar, M. (2016) · Cited by 4
Research works printed but not linked: 1
- Li, 2016, Effects of Vitamin D Supplementation on Glycaemic Control, Insulin Resistance and β Cell Function in Type 2 Diabetes Mellitus: A Meta-analysis, Chin. J. Evid.-Based Med., 16, 1080
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging
Bruins, M. J., Van Dael, P., & Eggersdorfer, M. (2019) · Nutrients · doi:10.3390/nu11010085 · Cited by 223
“Changes in other parameters such as fasting blood glucose and hemoglobin A1c (HbA1c) were relatively small and did not achieve statistical significance [137].”
BackgroundArgano, C., Mirarchi, L., Amodeo, S., Orlando, V., Torres, A., & Corrao, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015485 · Cited by 204
“In another meta-analysis, vitamin D intake significantly decreased insulin resistance in people with T2DM [216].”
BackgroundDong, B., Zhou, Y., Wang, W., Scott, J., Kim, K., Sun, Z., Guo, Q., Lu, Y., Gonzales, N. M., Wu, H., et al. (2020) · Hepatology · doi:10.1002/hep.30937 · Cited by 180
“1572 and T2DM has been spurred in recent years, different patient cohorts have shown inconsistent effectiveness of vitamin D supplementation.(25,43,44) One challenge in targeting VDR is confirming the efficacy of vitamin D and its synthetic analogs, particularly because the local concentration of activated vitamin D i…”
BackgroundRebelos, E., Tentolouris, N., & Jude, E. (2023) · Drugs · doi:10.1007/s40265-023-01875-8 · Cited by 167
“, an index of insulin resistance) was improved [134].”
Background
Metadata
- Authors
- Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y.
- Affiliations
- Peking University (CN)
- Corresponding author
- Zhang, Yumei
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-03-19
- Volume
- 10
- Issue
- 3
- Pages
- 375
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5872793
- OpenAlex
- W2789558207
- Cited by
- 266
- References
- 50
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 44 · 2023: 48 · 2022: 51 · 2021: 35 · 2020: 18 · 2019: 23 · 2018: 6
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81573429, 2017YFD0400602)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- vitamin D supplementation, type 2 diabetes, glycemic control, insulin resistance, HOMA-IR, serum 25-hydroxyvitamin D, fasting blood glucose, HbA1c, fasting insulin, vitamin D deficiency, dose and duration effects, obesity, Middle Eastern populations
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin Resistance, Male, Middle Aged, Vitamin D, Vitamin D Deficiency, Biomarkers, Treatment Outcome, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.